Stock listing

Proteome Sciences Plc

Selected listing: PRM · LSE · GBX · GB

Proteome Sciences Plc (LSE:PRM), Health Technology. Latest release Sep 16, 2026: Appointment of Non-Executive Director.

PRM:LSEGBXGBUpdated October 3, 2026

Ticker: LSE:PRM
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LSE
Currency: GBX

About Proteome Sciences Plc

The company focuses on providing proteomics services and products, leveraging advanced technologies for research and development in the life sciences sector. Proteome Sciences aims to enhance understanding of biological processes through its innovative solutions.

Latest news from Proteome Sciences Plc

Appointment of Non-Executive Director

September 16, 2026

Further GCLP Chemoproteomics contract secured

September 15, 2026

Target engagement/chemoproteomics contract

June 22, 2026

Annual General Meeting Statement

May 14, 2026

Final results for the year ended 31 December 2025

April 15, 2026

All Proteome Sciences Plc news →

Events

Replays

PROTEOME SCIENCES PLC (PRM) — Final Results for the Year Ending 31st December 2024
Fri, Apr 11, 2025 · 05:30 AM ET
Watch
PROTEOME SCIENCES PLC (PRM) — Annual General Meeting
Thu, May 16, 2024 · 07:00 AM ET
Watch
PROTEOME SCIENCES PLC (PRM) — Half Year Results
Tue, Sep 19, 2023 · 05:00 AM ET
Watch

Research Proteome Sciences Plc

Proteome Sciences Plc company profile

View the public company page for Proteome Sciences Plc on 6ix.

Proteome Sciences Plc news

Read company news and market updates connected to Proteome Sciences Plc.

Proteome Sciences Plc investor events

Find investor webinars, events, and replay context for Proteome Sciences Plc.